Reaction: Deucravacitinib to 1 product

Reaction
Deucravacitinib
DB16650
BMT-153261
DBMET03545
Reaction type
N-demethylation
Direction
Major circulating metabolite?
Yes
Spontaneous?
No
Activity
active
References
  1. International Society for the Study of Xenobiotics: ABSTRACTS FROM THE ISSX/MDO 2022 MEETING [Link]
  2. FDA Approved Drug Products: SOTYKTU (deucravacitinib) tablets, for oral use [Link]
Comments
Not Available
Enzymes
EnzymeKmVmaxRole
Cytochrome P450 1A2Not AvailableNot Availableimplied